Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03281590 · ClinicalTrials.gov registry record
Stroke and Cerebrovascular Diseases Registry
A clinical trial, sponsored by University of New Mexico.
- Completed
- Registry status
- 4,594
- Enrollment target
NCT03281590: Completed study, sponsored by University of New Mexico.
NCT03281590 is a clinical trial that has completed, run by University of New Mexico. The registered enrollment target is 4,594 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03281590 has completed, sponsored by University of New Mexico.
- COMPLETED
- Registry status
- 4,594 participants
- Enrollment target
Study Summary
This is a single institutional registry database for the patients with stroke and cerebrovascular diseases. Stroke is the fifth leading cause of death in the United States. Despite extensive research, most of the patients die or suffer from varying degree of post-stroke disabilities due to neurologic deficits. This registry aims to understand the disease and examine the disease dynamics in the local community.
Primary Outcome
Prospective and retrospective analysis of patients with the acute brain injury, transient ischemic attack, acute and chronic ischemic and hemorrhagic stroke, subarachnoid hemorrhage, and cerebral venous thrombosis from pre-hospitalization, hospitalization (in-patient) and post hospitalization (clinic) data to determine factors which can predict stroke outcome.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,594 participants |
| Start Date | 2017-09-06 |
| Est. Completion | 2022-06-10 |
What the finished NCT03281590 record still lists
NCT03281590 is an observational study that tracks outcomes without assigning an intervention. Its 4,594 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT03281590 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03281590 about?
NCT03281590 is a clinical study titled "Stroke and Cerebrovascular Diseases Registry". This is a single institutional registry database for the patients with stroke and cerebrovascular diseases. Stroke is the fifth leading cause of death in the United States. Despite extensive research, most of the patients die or suffer from varying degree of post-stroke disabilities due to neurologi...
What is the current status of trial NCT03281590?
This trial is currently completed. The enrollment target is 4,594 participants. The study started on 2017-09-06. Estimated completion is 2022-06-10.
Who is sponsoring clinical trial NCT03281590?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05768217 · 4,600 participants · NA
Community Resiliency Collective Efficacy Intervention
- NCT06535139 · 4,630 participants · NA
ReMARK: Addressing Disparities in Rural HPV-related Cancer Prevention
- NCT06702878 · 4,514 participants · Phase 3
Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections
- NCT06533111 · 4,500 participants · NA
Improving Surgical Patient Outcomes Through Implementation of a SemiStructured Intraoperative Anesthesia Handoff Tool
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI